✦ LIBER ✦

EFFECT OF THE DIPEPTIDYL PEPTIDASE-4 INHIBITOR SITAGLIPTIN IN OLDER ADULTS WITH TYPE 2 DIABETES MELLITUS

✍ Scribed by Sara Stafford; Dariush Elahi; Graydon S. Meneilly

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of the dipeptidyl pe

✍ I. Raz; M. Hanefeld; L. Xu; C. Caria; D. Williams-Herman; H. Khatami; Sitaglipti 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 160 KB

The dipeptidyl peptidase-4 inhibitor PHX

✍ G. Garcia-Soria; G. Gonzalez-Galvez; G. M. Argoud; M. Gerstman; T. W. Littlejohn 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Long-term safety, tolerability, and effi

✍ Masato Odawara; Takashi Kadowaki; Naoko Tajima; Mikio Nishii; Tadaaki Taniguchi; 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 377 KB

Effect of sitagliptin, a dipeptidyl pept

✍ L. Xu; C. Dalla Man; B. Charbonnel; G. Meninger; M. J. Davies; D. Williams-Herma 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Efficacy and safety of the dipeptidyl pe

✍ K. Hermansen; M. Kipnes; E. Luo; D. Fanurik; H. Khatami; P. Stein; Sitagliptin S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Saxagliptin: a new dipeptidyl peptidase-

✍ Carolyn F. Deacon; Jens J. Holst 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 223 KB